Arlen Wilcox (A Wilcox)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Top Venues

BMJ (Clinical research ed.)

This page only lists publications with an associated author ORCID identifier.

Publications

J M McGree, C Hockham, S Kotwal, Arlen Wilcox, A Bassi, C Pollock, L M Burrell, T Snelling, V Jha, M Jardine, M Jones, null null
Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial. Trials 23 (1) (2022)
Meg J Jardine, Sradha S Kotwal, Abhinav Bassi, Carinna Hockham, Mark A Jones, Arlen Wilcox, Carol A Pollock, Louise M Burrell, Vijay S Rathore, Christine R Jenkins, Lalit Gupta, Angus Graham Ritchie, Ashpak Bangi, Sanjay D'Cruz, Andrew J McLachlan, Simon R Finfer, Michelle M Cummins, Thomas L Snelling, Vivekananda Jha, null null
Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial. BMJ (Clinical research ed.) 379 (2022)
Carinna Hockham, Sradha Kotwal, Arlen Wilcox, Abhinav Bassi, James McGree, Carol Pollock, Louise M Burrell, Nikita Bathla, Mallikarjuna Kunigari, Vinay Rathore, Michael John, Enmoore Lin, Christine Jenkins, Angus Ritchie, Andrew McLachlan, Thomas Snelling, Mark Jones, Vivekanand Jha, Meg Jardine, null null
Protocol for the Controlled evaLuation of Angiotensin Receptor blockers for COVID-19 respIraTorY disease (CLARITY): a randomised controlled trial. Trials 22 (1) (2021)